United States · FDA National Drug Code directory
Venlafaxine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-021_ea404f6c-7e07-4779-a52c-8cffb92718ef
- Product NDC
- 68382-021
- Form
- TABLET
- Composition / generic term
- Venlafaxine
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080613
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68382-021-01) · 68382-021-01
- 500 TABLET in 1 BOTTLE (68382-021-05) · 68382-021-05
- 30 TABLET in 1 BOTTLE (68382-021-06) · 68382-021-06
- 1000 TABLET in 1 BOTTLE (68382-021-10) · 68382-021-10
- 60 TABLET in 1 BOTTLE (68382-021-14) · 68382-021-14
- 90 TABLET in 1 BOTTLE (68382-021-16) · 68382-021-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →